Recursion Pharmaceuticals... (RXRX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

7.00

0.86%

After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	44.58M	39.68M	10.00M	3.41M	1.71M
Cost of Revenue	42.59M	48.27M	9.10M	63.32M	45.81M
Gross Profit	1.99M	-8.59M	896.00K	-59.91M	-44.10M
Operating Income	-350.06M	-245.73M	-182.78M	-84.61M	-62.44M
Interest Income	19.12M	6.25M	73.00K	336.00K	1.74M
Pretax Income	-332.13M	-239.48M	-186.48M	-87.01M	-61.88M
Net Income	-328.07M	-239.42M	-178.07M	-87.88M	-62.52M
Selling & General & Admin	110.82M	81.60M	57.68M	25.26M	18.95M
Research & Development	241.23M	155.70M	135.27M	63.32M	45.81M
Other Expenses	-	-162.00K	-178.00K	-549.00K	-608.00K
Operating Expenses	352.05M	237.13M	192.78M	88.03M	64.15M
Interest Expense	97.00K	55.00K	2.95M	1.36M	635.00K
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	394.63M	285.41M	192.78M	88.03M	64.15M
Income Tax	-4.06M	-55.00K	-8.40M	876.00K	646.00K
Shares Outstanding (Basic)	207.85M	175.54M	170.27M	165.79M	165.79M
Shares Outstanding (Diluted)	207.85M	175.54M	170.27M	165.79M	165.79M
EPS (Basic)	-1.58	-1.36	-1.05	-0.52	-0.37
EPS (Diluted)	-1.58	-1.36	-1.05	-0.52	-0.37
EBITDA	-299.57M	-227.66M	-174.42M	-81.70M	-58.34M
Depreciation & Amortization	24.40M	19.49M	9.10M	4.44M	3.54M